ArticleBlood cancer journal2020

Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia.

Lu-Hong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.